A Review of Regulatory Guidelines on Stability Studies
Journal Title: The Journal of Phytopharmacology - Year 2019, Vol 8, Issue 3
Abstract
Stability could be an essential quality attribute; so, the stability program plays a very important role while manufacturing fresh pharmaceutical products. Particularly, this is in regard with the pharmaceutical preparations or formulations, which are to be distributed in various strengths and various types of packages for the purpose of marketing. It involves many samples to be tested at a given cost, and also involves testing large number of samples of various strengths, package types, many batches of different storage conditions, testing parameters and testing intervals. To design a successful stability-testing program, there are many regulatory guidance documents that should be consulted. These guidance documents provide information on how to conduct a stability program to ensure that appropriate data are generated in support of a new drug substance or product. This paper discusses the various guidelines governing the stability studies, particularly the FDA (Food and Drug Administration), ICH (The International Conference on Harmonization), CPMP (Committee for Proprietary Medicinal Products), & WHO (Word Health Organization)-their rules, regulations, and recommendations regarding stability studies. In this paper, details regarding the formation of International Conference on Harmonization, the regions involving it, the suggestions made by them, and the various guidelines issued by it, relating not only to stability studies but many other aspects relating to it, and an overview of various ICH stability guidelines, their names and the codifications, have been described briefly.
Authors and Affiliations
Ameena Yasmeen, Ghulamuddin Sofi
Keywords
Related Articles
- EP ID EP49938
- DOI https://search.crossref.org/?q=10.31254/phyto.2019.83011
- Views 254
- Downloads 0
Baillonella toxisperma improves sexual performance and protects against stress-induced reproductive dysfunction in male Wistar rats
Baillonella toxisperma Pierre (Sapotaceae) is a medicinal plant widely used in Central Africa against several diseases including erectile dysfunction and male infertility. However, no study dealing with these male repr...
Lipid Lowering potential of Andrographis paniculata (Nees)
Aim: Atherosclerosis and associated complications is now the major cause of myocardial morbidity and mortality worldwide. Therefore we have selected the Andrographis paniculata for the development of lipid lowering dru...
Evaluation of anxiolytic activity of W. Chinensis Merrill Leaves
Wedelia chinensis (family: Asteraceae), commonly known as Pilabhangra has been traditionally used for the treatment of various ailments like jaundice, diarrhoea, cephalahagia, respiratory disorders and to induce sleep,...
Evaluation of Salvia haematodes Linn for their antioxidant, anti-microbial, anti-lipoxygenase and anticholinesterase activity
The indigenous medicinal plant Salvia haematodes Linn (SAL) was screened for its pharmacological activities. The crude extract fractions were prepared in methanol, n-hexane, di chloromethane (DCM) and n-butanol by cold...
Ethnomedicinal, Antimicrobial and Pharmacological aspects of Malva parviflora Linn.: A review
Malva parviflora Linn. has shown its pharmacological potential in different ailments. Leaves are used in the management of wounds and swelling. A lotion made from the leaves is used to treat bruises and broken limbs. T...